Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
8.46
-0.04 (-0.47%)
At close: Oct 29, 2026, 4:00 PM EDT
8.46
0.00 (0.00%)
After-hours: Oct 29, 2026, 4:10 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $2.2 billion as of October 29, 2026. It is the 6,188th most valuable company in the world and the 1,711th biggest in the United States. Its market cap has increased by 166.35% in one year.
Market Cap
2.20B
Enterprise Value
2.34B
1-Year Change
166.35%
Global Rank
Country Rank
#1,711 United States
Category
ChartMarket Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $2.20B, a decrease of -69.62%. That is a compound annual growth rate of -18.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 2.20B | 164.36% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.31B |
| Pharvaris | 2.30B |
| Agios Pharmaceuticals | 2.28B |
| Harmony Biosciences Holdings | 2.24B |
| Xencor | 2.23B |
| Vera Therapeutics | 2.23B |
| Precigen | 2.18B |
| Immunome | 2.13B |